The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S,5R)-Methyl 2-(hydroxycarbamoyl)-3,3-dimethyl-7-oxo-4-thia-1-azaspiro[bicyclo[3.2.0]heptane-6,3'-pyrazole]-5'-carboxylate ID: ALA4879076
PubChem CID: 164626423
Max Phase: Preclinical
Molecular Formula: C12H14N4O6S
Molecular Weight: 342.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)C1=CC2(N=N1)C(=O)N1[C@@H](C(=O)ONO)C(C)(C)S[C@@H]12
Standard InChI: InChI=1S/C12H14N4O6S/c1-11(2)6(8(18)22-15-20)16-9(19)12(10(16)23-11)4-5(13-14-12)7(17)21-3/h4,6,10,15,20H,1-3H3/t6-,10+,12?/m0/s1
Standard InChI Key: TUDHZVJZOHKZTM-CNDFYXPKSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
32.8806 -14.2942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8764 -13.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0906 -13.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6089 -13.8882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0973 -14.5530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6929 -14.2821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9804 -14.6988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6974 -15.1074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8847 -15.1195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7097 -14.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7141 -15.1195 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5001 -15.3702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4928 -14.0355 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.7014 -13.4655 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
34.7600 -16.1530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2120 -16.7696 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.5680 -16.3194 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.3013 -15.7028 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.8317 -12.4351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3806 -11.8193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.0240 -12.2676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.7651 -11.4843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8279 -17.1024 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2798 -17.7189 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
7 6 1 0
7 8 1 0
1 9 1 0
9 11 1 0
10 1 1 0
10 11 1 0
11 12 1 0
12 7 1 0
7 13 1 0
13 10 1 0
10 14 1 6
12 15 1 6
15 16 2 0
15 17 1 0
9 18 2 0
3 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
17 23 1 0
23 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.33Molecular Weight (Monoisotopic): 342.0634AlogP: -0.25#Rotatable Bonds: 3Polar Surface Area: 129.89Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.32CX LogP: 0.05CX LogD: 0.05Aromatic Rings: ┄Heavy Atoms: 23QED Weighted: 0.41Np Likeness Score: 0.24
References 1. Alves NG, Bártolo I, Alves AJS, Fontinha D, Francisco D, Lopes SMM, Soares MIL, Simões CJV, Prudêncio M, Taveira N, Pinho E Melo TMVD.. (2021) Synthesis and structure-activity relationships of new chiral spiro-β-lactams highly active against HIV-1 and Plasmodium., 219 [PMID:33887681 ] [10.1016/j.ejmech.2021.113439 ]